Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 143,428 | 265,453 | 104,641 | 181,101 | 34,915 |
| Marketable Securities | 6,381 | 1,009 | 2,543 | 136,015 | 61,146 |
| Receivables | 2,360 | N/A | N/A | N/A | N/A |
| Inventories | 8,272 | 0 | N/A | N/A | N/A |
| Other current assets | 293 | 2,019 | 1,890 | 1,333 | 2,003 |
| TOTAL | $184,586 | $294,084 | $140,577 | $334,347 | $111,713 |
| Non-Current Assets | |||||
| PPE Net | 137,094 | 146,082 | 143,659 | 82,863 | 72,541 |
| Investments And Advances | 0 | 891 | 840 | 7,597 | 8,799 |
| Intangibles | 15,933 | 17,093 | 20,003 | 1,420 | 1,463 |
| Other Non-Current Assets | 45,320 | 46,302 | 57,277 | 42,683 | 26,865 |
| TOTAL | $198,347 | $210,368 | $221,779 | $134,563 | $109,668 |
| Total Assets | $382,933 | $504,452 | $362,356 | $468,910 | $221,381 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 431,901 | N/A | N/A |
| Accounts payable and accrued liabilities | 6,898 | 10,331 | 24,485 | 15,361 | 26,348 |
| Accrued Expenses | 40,580 | 42,708 | 41,825 | 51,387 | 36,771 |
| TOTAL | $54,944 | $58,283 | $500,861 | $368,995 | $68,134 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 104,586 | N/A | 306,349 | 254,353 |
| Other Non-Current Liabilities | 816,199 | 928,176 | 312,068 | 40,537 | 19,550 |
| TOTAL | $816,118 | $1,032,106 | $311,315 | $343,828 | $271,737 |
| Total Liabilities | $871,062 | $1,090,389 | $812,176 | $712,823 | $339,871 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 853,442 | 673,952 | 435,836 | 397,911 | 109,345 |
| Common Shares | 85 | 67 | 42 | 40 | 38 |
| Retained earnings | -3,375,248 | -2,961,684 | -2,378,488 | -1,961,921 | -1,615,131 |
| Other shareholders' equity | 2,167 | 1,060 | -2,310 | -1,736 | 1,440 |
| TOTAL | $-488,129 | $-585,937 | $-449,820 | $-243,913 | $-118,490 |
| Total Liabilities And Equity | $382,933 | $504,452 | $362,356 | $468,910 | $221,381 |